Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing

By LabMedica International staff writers
Posted on 01 Dec 2021

The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3. More...

7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow assay kits, demand growth of point-of-care testing, and rise in adoption of LFA kits due to their advantages over laboratory tests.

These are the latest findings of Persistence Market Research (New York City, NY, USA), a third-party research organization.

Lateral flow assays are mainly used for diagnostics for home testing, laboratory use, and point-of-care testing. The most widely applied and well-known applications of lateral flow assays are home pregnancy tests. The rising prevalence of infectious diseases is a key growth driver of the lateral flow assay market. The emergence of diseases such as coronavirus, Zika virus, Ebola, and others has increased the procurement of point-of-care testing devices and kits by international bodies such as UNICEF. Furthermore, the current COVID-19 pandemic has boosted the demand for lateral flow tests. COVID-19 infections are diagnosed with lateral flow assay-based tests across the world.

Mobile phones provide rapid results in real time, saving time and reducing result reporting delays. They also allow users to record the time and results of a test. Further, easy and cost-effective sharing of data along with cloud integration has resulted in better centralization and analysis of data using online information sharing platforms. This technology enables clinicians or patients in remote areas to image samples that can be used for TB and malaria diagnosis.

By product, LFA kits will hold a high share of 70% of the lateral flow assay market in 2021 and is expected to record a mid-single digit CAGR during the forecast period, led by rising adoption of products in this segment that offer ease of use, low cost, and ease of production. By indication, infectious disease is expected to hold a market share of well over 50% in 2021 and continue growing at a moderate rate in line with the increasing prevalence of infectious diseases globally. The high adoption of point-of-care testing for quick diagnosis at hospitals has led to hospital pharmacies holding a high market share. By region, North America held nearly 1/3 of the global market share in 2021, mainly due to a rise in health care expenditures, increasing adoption of lateral flow assays, and the presence of prominent players in the region.

"Although the COVID-19 pandemic boosted market growth in 2020, it is expected to be a temporary phase. However, developments such as smartphone-based readers for LFA will continue to provide fruitful growth opportunities for market players over the coming years," stated an analyst at Persistence Market Research.

Related Links:
Persistence Market Research


Gold Member
Serological Pipets
INTEGRA Serological Pipets
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test analyzes biomarkers in uterine fluid to detect endometrial cancer (Photo courtesy of 123RF)

ELISA-Based Test Uses Gynecologic Fluids to Detect Endometrial Cancer

Every year, 35 million postmenopausal women worldwide experience abnormal uterine bleeding (AUB), the primary trigger for initiating endometrial cancer diagnosis. Around 5% of these women will develop... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.